⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

November 1, 1961American Journal of Clinical Pathology

Malignant Peritoneal Mesothelioma

Álvaro Bolio-Cicero Jesús Aguirre Ruy Pérez-Tamayo

View at Publisher

Ask AI

Bookmark

Share

Abstract

Alvaro Bolio-Cicero, M.D., Jesús Aguirre, M.D., Ruy Peréz-Tamayo, M.D.; Malignant Peritoneal Mesothelioma., American Journal of Clinical Pathology, Volume

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bolio-Cicero et al. (1961) studied this question.

synapsesocial.com/papers/6a835135cd5bc3880318f977 https://doi.org/10.1093/ajcp/36.5.417

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1BRAF V600E–mutated marginal zone lymphoma may exhibit features that partially overlap with hairy cell leukemiaAmerican Journal of Clinical Pathology · 2026
2Preanalytical variables in surgical pathology: practical sources of diagnostic error before microscopic interpretationAmerican Journal of Clinical Pathology · 2026
3Risk factors for lymph node metastasis in a contemporary radical prostatectomy cohortAmerican Journal of Clinical Pathology · 2026
4How I diagnose Erdheim-Chester diseaseAmerican Journal of Clinical Pathology · 2026
5Optimizing diagnostic utility for diagnosis and management of Helicobacter pylori infections through combined microbiology and pathology approaches: a 7-year studyAmerican Journal of Clinical Pathology · 2026

Single-cohort next-generation sequencing analysis of 713 anaplastic thyroid carcinomas: unreported gene alterations and actionable targetsAmerican Journal of Clinical Pathology · 2026
Evaluation of a virulence gene repertoire as a means to investigate the role in the causal pathway to death of Escherichia coli isolated from postmortem specimens, northern TanzaniaAmerican Journal of Clinical Pathology · 2026
Measurement of hemolysis in packed red blood cell segments and units using H indexAmerican Journal of Clinical Pathology · 2026
Optical genome mapping refines diagnosis of high-grade myeloid neoplasms through detection of MECOM rearrangements cryptic to conventional karyotypeAmerican Journal of Clinical Pathology · 2026
The essentials—measurable residual disease in hematopoietic neoplasms: current testing landscape and future directionsAmerican Journal of Clinical Pathology · 2026

More from American Journal of Clinical Pathology